VYVANSE 60 MG CAPSULE

lisdexamfetamine dimesylate
$12.3566per EA
High Outlier
DEA Schedule CII

Strength

60 mg/1

NDC

59417010610

Classification

Brand

Dosage Form

CAPSULE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

LISDEXAMFETAMINE DIMESYLATE

Approval Type

New Drug (NDA)

FDA Application

NDA021977

On Market Since

12/10/2007

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price History

1W

0.0%

1M

-0.0%

3M

-0.0%

6M

-0.1%

1Y

-0.3%

3Y

+4.5%

5Y

+15.6%

All

+108.2%